Page results
-
Our education department at the Royal London Hospital for Integrated Medicine, runs courses in integrated medicine for statutory registered health professionals.
-
The Integrated Children’s and Adolescent Service has been established to provide complementary care alongside orthodox treatments. The clinic sees children up to 18 years old with a wide variety of illnesses.
-
Information about the integrated general medicine service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated occupational therapy service at the Royal London Hospital for Integrated Medicine
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
-
The main theatres suite, comprising 12 operating theatres, is located on level P3 of University College Hospital.
-
Our clinical work includes thoracic surgery, obstetrics, inpatient and day-case surgery, chronic and acute pain, pre-assessment and exercise testing, imaging, endoscopy and radiotherapy.
-
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
You can use MyCare on your mobile, tablet or computer to securely view and manage information about your health and care at UCLH.
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
File results
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0156 - Digital sepsis alerts for obstetric patients
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0175 - Treatment for Myelofibrosis